Pregnant patients with lupus and concomitant APS had an 18-fold higher risk for a cardiovascular event during and up to 6 weeks postpartum than...
Of the 35 trials studied, most involved patients with atopic dermatitis.
“This is the first and only randomized trial to show the superiority of longer duration over shorter duration of anticoagulation therapy for...
The efficacy data in the phase 3 trials will be key to the success of these drugs. “That is a very important part of the puzzle that is still...
The switch resulted in more bleeding without any reduction in thromboembolic complications or all-cause mortality.
People on Medicare may in 2026 see prices drop for 10 medicines, including pricey diabetes, cancer, blood clot, and arthritis treatments.
A new consensus statement on transcatheter left atrial appendage closure tightens standards for patient selection as well as operator experience...
The nationwide recall is because of the detection of the nitrosamine impurity, N-nitroso-dabigatran.
In an in-hospital anticoagulation trial, the primary COVID endpoint was missed but a survival benefit is observed.
“It’s unbelievable how much we’ve accomplished in the last 20 years” in cardiology, said Dr. Steven E. Nissen.
From the Journals
Artificial sweeteners are “generally recognized as safe” by the FDA, so there is no requirement for long-term safety studies, and little is known...